General Practitioners' Experiences with Assessing Distress in Cancer
the Cancer Therapy Advisor take:
Five themes were observed among general practitioners (GPs) assessing patients with cancer for psychological distress, according to an article posted online in the European Journal of Cancer Care.
The study focused on seven GPs who were interviewed regarding their experiences with assessing psychological distress in patients.
The first theme was Being in a Relay. In this category, GPs viewed the assessment of distress as being like a relay race baton, with different health care professionals comprising the team. The GPs reported being most involved at diagnosis and in the palliative phase.
The second theme compared the assessment process to being in a relationship. The connection was the doctor-patient relationship, which was viewed as being a strong facilitator to assessment for distress.
The third theme was Being Skilled. In this theme, the GPs perceived themselves to be skilled enough at assessment to adopt a patient-centered approach.
The fourth theme involved barriers and was termed Being Challenged. This theme identified obstacles GPs faced when performing psychological assessments. The challenges included the GPs’ personal emotions, patient-related factors, time, and family (presented as a duality of barrier and facilitator).
The fifth theme was the Intruder in the Room. GPs did not perform validated screenings because they viewed the assessment as an intruder in the doctor-patient relationship.
The study suggests future research focus on objective assessments of GPs and their usage of distress assessments.
Five themes were observed among general practitioners assessing patients with cancer for psychological distress.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- A Vegan Diet and Cancer
- Are Next-Gen Antibody-Drug Conjugates a Path Forward for Non-Hodgkin Lymphoma and Myeloma?
- Ponatinib Tops Bosutinib for Third-Line Treatment of CML in a Comparative Analysis
- Apalutamide Does Not Diminish Quality of Life in Nonmetastatic Castration-Resistant Prostate Cancer
- Chemotherapy Plays a Role in Skeletal Muscle Atrophy in Patients With Breast Cancer
- FDA-Approved Breast Cancer Drug Treatments
- A Trained Dog Smells Early-Stage Lung Cancer With a High Degree of Accuracy
- FDA-Approved Prostate Cancer Drug Treatments
- FDA-Approved Colorectal Cancer Drug Treatments
- Synthetic or Plant-Based Cannabis for Symptom Relief in Patients With Cancer: Do We Have Any Evidence?
- A Big BiTE: Tetravalent BiTE Highly Potent in HER2-positive Breast Cancer Models
- Plastics and Cancer
- Real World Experience Differs from Trial Results for Niraparib in Recurrent Ovarian Cancer
- Trastuzumab Biosimilar Demonstrated Equivalent Efficacy Across Clinical Settings
- Plasma NGS Should Be Routine in Metastatic NSCLC, Say Researchers